Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.

Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB.

N Engl J Med. 2002 Mar 14;346(11):822-9.

2.

Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.

Schneeweiss S, Soumerai SB, Maclure M, Dormuth C, Walker AM, Glynn RJ.

Clin Pharmacol Ther. 2003 Oct;74(4):388-400.

PMID:
14534526
3.
4.

Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents.

Schneeweiss S, Dormuth C, Grootendorst P, Soumerai SB, Maclure M.

Med Care. 2004 Jul;42(7):653-60.

PMID:
15213490
5.

Physician gender and changes in drug prescribing after the implementation of reference pricing in British Columbia.

Duetz MS, Schneeweiss S, Maclure M, Abel T, Glynn RJ, Soumerai SB.

Clin Ther. 2003 Jan;25(1):273-84.

PMID:
12637126
6.

Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization.

Schneeweiss S, Soumerai SB, Glynn RJ, Maclure M, Dormuth C, Walker AM.

CMAJ. 2002 Mar 19;166(6):737-45.

7.

Prescription duration after drug copay changes in older people: methodological aspects.

Schneeweiss S, Maclure M, Soumerai SB.

J Am Geriatr Soc. 2002 Mar;50(3):521-5.

PMID:
11943050
8.
10.

The effect of incentive-based formularies on prescription-drug utilization and spending.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG.

N Engl J Med. 2003 Dec 4;349(23):2224-32.

12.
13.

Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs.

Grootendorst PV, Dolovich LR, O'Brien BJ, Holbrook AM, Levy AR.

CMAJ. 2001 Oct 16;165(8):1011-9.

14.

Evaluation of the total cost of treating elderly hypertensive patients with ACE inhibitors: a comparison of older and newer agents.

Small RE, Freeman-Arnold SB, Goode JV, Pyles MA.

Pharmacotherapy. 1997 Sep-Oct;17(5):1011-6.

PMID:
9324190
15.

Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker.

Okano GJ, Rascati KL, Wilson JP, Remund DD, Grabenstein JD, Brixner DI.

Clin Ther. 1997 Nov-Dec;19(6):1433-45; discussion 1424-5.

PMID:
9444451
16.

Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.

Gambassi G, Lapane KL, Sgadari A, Carbonin P, Gatsonis C, Lipsitz LA, Mor V, Bernabei R.

Arch Intern Med. 2000 Jan 10;160(1):53-60.

PMID:
10632305
17.

Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.

Mazzaglia G, Mantovani LG, Sturkenboom MC, Filippi A, Trifirò G, Cricelli C, Brignoli O, Caputi AP.

J Hypertens. 2005 Nov;23(11):2093-100.

PMID:
16208153
18.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk